Filament Health Corp News - FH | Aktien NEO Exchange

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

PharmAla Biotech and Filament Health Announce Release of Second Batch of GMP MDMA Capsules

VANCOUVER, British Columbia, Nov. 15, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”...

PharmAla Biotech and Filament Health Announce Release of GMP MDMA Capsules

VANCOUVER, British Columbia, April 11, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”...

KCSA Mental Health Virtual Investor Conference: Presentations Now Available for Online Viewing

NEW YORK, Dec. 16, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor...

Psyence and Filament Health Announce Worldwide Licensing Agreement of Psilocybin Capsule for Palliative Care

VANCOUVER, British Columbia, Dec. 15, 2022 (GLOBE NEWSWIRE) -- Filament Health Corp. (OTCQB:FLHLF) (NEO:FH...

KCSA Mental Health Virtual Investor Conference Agenda Announced for December 15th

NEW YORK, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor...

Psyence Group Completes Export of Psilocybin Mushrooms to Canada

TORONTO, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the...

Filament Health to Webcast Live at VirtualInvestorConferences.com April 28th

VANCOUVER, British Columbia, April 25, 2022 (GLOBE NEWSWIRE) -- Filament Health (OTCQB:FLHLF) (NEO:FH...

Psyence and Filament Health Enter Into Exclusive Licensing Agreement for Natural Psilocybin Products

VANCOUVER, British Columbia, April 19, 2022 (GLOBE NEWSWIRE) -- Psyence Group Inc (CSE: PSYG | OTCQB: PSYGF...

Amended Statement of Ownership (sc 13g/a)

THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Filament Health Corp (FH)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

FH Nachrichten

PharmAla Biotech and Filament Health Announce Release of Second Batch of GMP MDMA Capsules

PharmAla Biotech and Filament Health Announce Release of GMP MDMA Capsules

KCSA Mental Health Virtual Investor Conference: Presentations Now Available for Online Viewing

Psyence and Filament Health Announce Worldwide Licensing Agreement of Psilocybin Capsule for Palliative Care

KCSA Mental Health Virtual Investor Conference Agenda Announced for December 15th

Psyence Group Completes Export of Psilocybin Mushrooms to Canada

Filament Health to Webcast Live at VirtualInvestorConferences.com April 28th

Psyence and Filament Health Enter Into Exclusive Licensing Agreement for Natural Psilocybin Products

Amended Statement of Ownership (sc 13g/a)

Current Report Filing (8-k)

FH Finanzen

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Filament Health Corp (FH) News

Filament Health Corp (FH)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

FH Nachrichten

PharmAla Biotech and Filament Health Announce Release of Second Batch of GMP MDMA Capsules

PharmAla Biotech and Filament Health Announce Release of GMP MDMA Capsules

KCSA Mental Health Virtual Investor Conference: Presentations Now Available for Online Viewing

Psyence and Filament Health Announce Worldwide Licensing Agreement of Psilocybin Capsule for Palliative Care

KCSA Mental Health Virtual Investor Conference Agenda Announced for December 15th

Psyence Group Completes Export of Psilocybin Mushrooms to Canada

Filament Health to Webcast Live at VirtualInvestorConferences.com April 28th

Psyence and Filament Health Enter Into Exclusive Licensing Agreement for Natural Psilocybin Products

Amended Statement of Ownership (sc 13g/a)

Current Report Filing (8-k)

FH Finanzen

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen